20th International Conference on Pharmaceutical Drug Design and Adverse Effect
|20th International Conference on Pharmaceutical Drug Design and Adverse Effect|
|Date||November 19 - 20, 2018|
The ICPDDAF 2018: 20th International Conference on Pharmaceutical Drug Design and Adverse Effect aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Drug Design and Adverse Effect. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Drug Design and Adverse Effect.
ICPDDAF 2018 has teamed up with the Special Journal Issue on Pharmaceutical Drug Development and Adverse Effects.
We solicit your gracious presence at the upcoming 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety scheduled to happen during July 17-18, 2017 in Munich, Germany focussing on the advancements in emerging research and technologies in pharmacovigilance, clinical trials and risk management.
The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. 9th International Conference and Exhibition on Pharmacovigilance & Drug Safety emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.
Theme: “Advanced Regulatory Compliance in Pharmacovigilance Operations and Innovations”
Conference Aims and Objectives The ICPDDAF 2018: 20th International Conference on Pharmaceutical Drug Development and Adverse Effects aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Drug Development and Adverse Effects. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Drug Development and Adverse Effects.
The tentative scientific programme will be released soon
Abstracts/Full-Text Paper Submission Deadline December 10, 2017
Notification of Acceptance/Rejection December 31, 2017
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline October 23, 2018
Conference Dates November 19 - 20, 2018
Please ensure your submission meets WASET's strict guidelines for
accepting scholarly papers. Downloadable versions of the check list for
Full-Text Papers and
Please refer to the Paper Submission GUIDE before submitting your paper.
International Scientific Committee
Suleyman Akocak Adiyaman University, TR
Arzum Erdem Gursan Ege University, TR
Lei Mei Agilent Technologies, US
Chun Wu Mount Marty College, US
Ankit Gupta University of Chicago, US
Kal Ramnarayan Sapient Discovery, US
Xintong Wang Vanderbilt University, US
Gwo-Yu Chuang National Institutes of Health, US
Shashikant Srivastava Ut Southwestern Medical Center, US
Mohan Boggara Rensselaer Polytechnic Institute, US
Chandan Thomas Lake Erie College of Osteopathic Medicine School of Pharmacy, US
Subeena Sood Medstar Health Research Institute, US
Boojala Vijay B Reddy Queens College - City University of New York, US
Zhengwu Lu Abbott Laboratories, US
David Stiles Medtronic, US
Ching-An Peng Michigan Technological University, US
Sani Ismaila Usmanu Danfodiyo University, NG
Farid Semsarha Mim Daroo Pharmaceutical Co., IR
Gowri Meiyazhagan Periyar University, IN
Emmanuel Oladayo Olawode Rhodes University, ZA
Aslam Khan King Saud Bin Abdulaziz University for Health Sciences, SA
Sajeev Babasahib Ahalia School of Pharmacy, IN
Moulay Alaoui-Jamali Mcgill University, CA
Rose Anne Chua National University, PH
Yogesh Dalvi Pushpagiri Institute of Medical Sciences and Research Centre, IN
Pedro Abreu School of Health Sciences and Technologies of the University Lusófona, Portugal
Tasnuva Tamanna Swinburne University of Technology, Australia
Tommaso Adamo University of Salento, Italy
Simona Dostalova Mendel University in Brno, Czech Republic
Merita Dauti State University of Tetova, Macedonia
Thitaporn Thoopputra University of Newcastle, Australia
Arpa Petchsomrit Prince of Songkla University, Thailand
Yaowaporn Sangsen Prince of Songkla University, Thailand
Tanvir Ahmed Griffith University, Australia
Zhong-Ru Xie University of Georgia,
Alaa Hamed Salama National Resaerch Center,
Ali Saad Ahmadi Hospital, EG
Sandeep Goyal Baba Farid University of Health Sciences, IN
Lola Alimkhodjaeva National Research Center of Oncology,
Ibrahim Labouta Alexandria University, EG
Preyesh Stephen University Laval, CA
Anton Larenkov Burnasyan Federal Medical Biophysical Center, Russian Federation
World Academy of Science, Engineering and Technology keenly seeks enthusiastic academicians, scholars and students who would love to contribute to the conference in the following positions:
Keynote/Invited/Plenary Speaker Eminent and outstanding scientists and researchers are kindly invited to deliver speech as Keynote/Invited/Plenary Speaker.
Conference Program Chair During the Conference Days Academicians are kindly invited to act as a Program Chair to manage and coordinate the sessions (invite and introduce the session chairs at the beginning of the sessions, provide the necessary information to the session chairs).
Conference General Chair, Publicity Chair Academicians are kindly invited to contribute, manage and promote the conference in academic circles.
Special Session / Workshop Organizer Each special session or workshop should include 5 to 10 oral & e-poster (a short electronic presentation including discussions will last in 5 min. with the oral presentations) presentations.
Benefits of being conference volunteer
* Free Conference Registration
* Certificate of contribution
* Travel and Accommodation charges are not covered.